J. Andrews
S. Gephart
UArizona may submit one application for only one component (A or B).
The purpose of this NOFO is to enhance PQCs’ capacity to make measurable improvements in perinatal healthcare and health outcomes statewide. Component A will support increasing capacity of PQCs to rapidly conduct population-level perinatal QI initiatives, with a focus on ensuring an equitable distribution of benefits from QI initiatives. Component B will support the provision of technical assistance, trainings, and capacity building for all PQCs in the US to improve uptake of perinatal QI initiatives nationwide.
Limited Submission language from the solicitation: CDC will consider any applications non-responsive, and it will not receive further review if the following criteria is not met: Applicants may only apply for one component (A or B). Applying to more than one component will deem the application non-responsive.
No applicants // Limit: 1 // Tickets Available: 1
Only one application per organization will be considered for either Components A and B or Components A, B, and C. Applicants must submit one application, but with separate work plans and budgets for each component.
The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health, Division of Environmental Health Science and Practice announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement to strengthen and modernize environmental health data and surveillance in the United States. The purpose of the funding is to continue building public health capacity and expertise in environmental health surveillance and to modernize data systems to empower public health practitioners, healthcare providers, community members, policy members, and others to make information-driven decisions that affect their health. Since 2002, the Environmental Public Health Tracking Program has provided the United States with accurate and timely standardized information from a nationwide network of environmental health data to help drive actions to improve the health of communities. The information is shared via a network of people and the Environmental Public Health Tracking Network, a web-based system of integrated health and environmental data with components at the national, state, and local levels.
No applicants // Limit: 1 // Tickets Available: 1
Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to support a network of US institutions that can: a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.
No applicants // Limit: 1 // Tickets Available: 1
The purpose of this Notice of Funding Opportunity (NOFO) is to conduct high quality clinical and applied fungal public health research activities to improve fungal public health outcomes in the United States and territories. Projects may be quantitative, qualitative, or mixed-methods epidemiological studies, laboratory-based studies, or other types of research projects focusing on:
a) Improving the understanding of fungal disease epidemiology;
b) Optimizing the diagnosis and treatment of patients with fungal diseases;
c) Understanding the impact of public health interventions to mitigate the impact of fungal diseases.
No applicants // Limit: 1 // Tickets Available: 1
This NOFO intends to support research to: 1) optimize and standardize implementation of existing strategies to reduce the abundance of host-seeking Ixodes scapularis nymphs infected with human pathogens, especially Lyme disease spirochetes (DIN); 2) evaluate efficacy and reproducibility of operational use (e.g., in the hands of pest control professionals or the public, as appropriate) of these protocols in high-risk settings (e.g., wooded residential properties, high-use wooded recreational areas) across the Midwest, Northeast and Mid-Atlantic United States where baseline DIN is elevated; and 3) develop standard operating procedures that may be used by homeowners or vector control professionals to implement these interventions within communities at risk for exposure to Lyme disease spirochetes and other I. scapularis-borne pathogens.
None.
None.
None.
None.